Skip to content

Effect and mechanism of percutaneous electrical nerve stimulation on functional constipation in children

Effect and mechanism of percutaneous electrical nerve stimulation on functional constipation in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059549
Enrollment
Unknown
Registered
2022-05-04
Start date
2022-04-30
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional constipation inchildren

Interventions

Lactulose group:Oral lactulose
TNES group:Percutaneous electrical stimulation

Sponsors

The Second Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Aged 4-14 years; 2. Meet the diagnostic criteria of Rome IV functional constipation; 3. Eliminate constipation caused by food allergy (such as milk, eggs and other foods); 4. Can persist in participating in the experiment interviewees; 5. Children >4 years of age meet two or more of the following diagnostic criteria for Rome IV functional constipation, and do not meet the diagnostic criteria for irritable bowel syndrome, and symptoms occur at least once a week for more than 2 months: (1) No more than 2 bowel movements per week; (2) Fecal incontinence at least once a week; (3) Have a history of fecal retention or have a posture related to fecal retention; (4) Difficult or painful defecation; (5) Large fecal mass in the rectum; (6) The excrement is so thick that it clogs the sewer.

Exclusion criteria

Exclusion criteria: 1. Refuse to sign informed consent; 2. Recently taking motor promoting drugs, anticholinergic drugs or dopaminergic drugs; 3. History of abdominal surgery; 4. Diabetes or other metabolic diseases; 5. Patients with liver and gallbladder diseases; 6. Allergy to equipment components; 7. Patients who refuse to take stool and blood samples.

Design outcomes

Primary

MeasureTime frame
Fecal intestinal flora;Therapeutic response rate;Gastric dynamic element;IL-6;IL-12;New people with poison;

Secondary

MeasureTime frame
Heart rate variability (HRV);Wexner Constipation Score (WCS);Bristol Stool Scale;

Countries

China

Contacts

Public ContactZhu Danrong

The Second Affiliated Hospital of Nanjing Medical University

zhudanrong@njmu.edu.cn+86 13032552597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026